Skip to main content
. 2014 Mar 1;22(7):2141–2148. doi: 10.1016/j.bmc.2014.02.038

Table 1.

Antiviral activity of camphor-based compounds 15 against influenza virus A/California/7/09 (H1N1)pdm09 in MDCK cells

Compound CTD50a, μM ED50b, μM SIc
1 3289.5 ± 216.0 1644.7 ± 144.4 2
2a 283.6 ± 25.4 9.3 ± 0.8 30
2b 1346.6 ± 126.1 15.1 ± 1.1 89
2c 1256.3 ± 114.2 22.8 ± 2.3 55
2d 390.1 ± 35.9 24.2 ± 2.1 16
2e 2216.2 ± 214.8 45.0 ± 3.9 49
2f >1072.9 351.4 ± 32.3 3
2g >1067.0 373.4 ± 35.1 3
3b 5.4 ± 0.4 0.77 ± 0.1 7
3c 10.4 ± 1.0 3.2 ± 0.2 3
3e 14.4 ± 1.5 4.4 ± 0.3 3
3f >638.2 153.2 ± 11.9 4
3g >635.5 207.6 ± 19.5 3
4b 110.3 ± 9.1 110.1 ± 10.4 1
4c 697.6 ± 72.2 40.4 ± 3.8 17
5f 30.1 ± 2.9 15.0 ± 1.2 2
5g 32.9 ± 2.7 4.2 ± 0.0 8
Rimantadine 335.2 ± 26.8 67.0 ± 4.9 5
Amantadine 284.1 ± 21.4 64.2 ± 4.7 4
Deitiforin 1266.2 ± 81.5 208.6 ± 15.4 6
Ribavirind >2000.0 24.6 >81.0
a

CTD50—cytotoxic concentration; the concentration resulting in death of 50% of cells.

b

ED50—50% effective concentration; the concentration leading to 50% inhibition of virus replication.

c

SI—selectivity index, ratio CTD50/ED50.

d

Data are taken from Ref. 29.